BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 11289028)

  • 1. Pharmaceutical sector in transition--a cross sectional study in Vietnam.
    Falkenberg T; Nguyen TB; Larsson M; Nguyen TD; Tomson G
    Southeast Asian J Trop Med Public Health; 2000 Sep; 31(3):590-7. PubMed ID: 11289028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [An analysis of the pharmaceuticals market in Vietnam].
    Simonet D
    Sante; 2001; 11(3):155-60. PubMed ID: 11641078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmaceutical policy of the Andean sub-region.
    Essent Drugs Monit; 1993; (16):13-5. PubMed ID: 12319050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Evaluation of prescription practices and of the rational use of medicines in Niger].
    Mallet HP; Njikam A; Scouflaire SM
    Sante; 2001; 11(3):185-93. PubMed ID: 11641083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of decentralization on health services in Uganda: a look at facility utilization, prescribing and availability of essential drugs.
    Anokbonggo WW; Ogwal-Okeng JW; Obua C; Aupont O; Ross-Degnan D
    East Afr Med J; 2004 Feb; Suppl():S2-7. PubMed ID: 15125109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monitoring of national drug policies--regional comparison between Bulgaria, Romania, Macedonia, Bosnia Herzegovina.
    Petrova GI
    Cent Eur J Public Health; 2001 Nov; 9(4):205-13. PubMed ID: 11787250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Introduction of direct-to-consumer advertising of prescription drugs in Canada: an opinion survey on regulatory policy.
    Mintzes B; Barer M; Lexchin J; Bassett KL
    Res Social Adm Pharm; 2005 Jun; 1(2):310-30. PubMed ID: 17138480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmaceuticals--strategic considerations in health reforms in Pakistan.
    Nishtar S
    J Pak Med Assoc; 2006 Dec; 56(12 Suppl 4):S100-11. PubMed ID: 17595837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Centralized purchasing of essential drugs, a priority for the health care systems of developing countries].
    Blaise P; Dujardin B; de Béthune X; Vandenbergh D
    Sante; 1998; 8(3):217-26. PubMed ID: 9690323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prescription practices of public and private health care providers in Attock District of Pakistan.
    Siddiqi S; Hamid S; Rafique G; Chaudhry SA; Ali N; Shahab S; Sauerborn R
    Int J Health Plann Manage; 2002; 17(1):23-40. PubMed ID: 11963441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of prescribing practices between public and private sector physicians in Uganda.
    Ogwal-Okeng JW; Obua C; Waako P; Aupont O; Ross-Degnan D
    East Afr Med J; 2004 Feb; Suppl():S12-6. PubMed ID: 15125111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative quality of private and public health services in rural Vietnam.
    Tuan T; Dung VT; Neu I; Dibley MJ
    Health Policy Plan; 2005 Sep; 20(5):319-27. PubMed ID: 16076933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Mechanism and implication of regulation of the pricing of essential medicines in the private pharmaceutical sector in Mali].
    Maïga D; Maïga S; Maïga MD
    Med Trop (Mars); 2010 Apr; 70(2):184-8. PubMed ID: 20486360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Public-private partnerships for health: their main targets, their diversity, and their future directions.
    Widdus R
    Bull World Health Organ; 2001; 79(8):713-20. PubMed ID: 11545327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of availability, accessibility and prescribing pattern of medicines in the Islamic Republic of Iran.
    Cheraghali AM; Nikfar S; Behmanesh Y; Rahimi V; Habibipour F; Tirdad R; Asadi A; Bahrami A
    East Mediterr Health J; 2004 May; 10(3):406-15. PubMed ID: 16212218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Essential drugs in the Gambia.
    Jallow MT
    World Health Forum; 1993; 14(2):136-9. PubMed ID: 8185753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Building the national drug policy on evidence--a cross sectional study on assessing implementation in Lao PDR.
    Paphassarang C; Wahlström R; Phoummalaysith B; Boupha B; Tomson G
    Southeast Asian J Trop Med Public Health; 2002 Sep; 33(3):647-53. PubMed ID: 12693605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of the impact of market regulation in Mali on the price of essential medicines provided through the private sector.
    Maïga D; Williams-Jones B
    Health Policy; 2010 Oct; 97(2-3):130-5. PubMed ID: 20435368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implementing and using quality measures for children's health care: perspectives on the state of the practice.
    Shaller D
    Pediatrics; 2004 Jan; 113(1 Pt 2):217-27. PubMed ID: 14702504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of the pharmaceuticals market and its technological development in Turkey.
    Kisa A
    Int J Technol Assess Health Care; 2006; 22(4):537-42. PubMed ID: 16984690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.